Acutaas Chemicals Ltd
NSE:ACUTAAS

Watchlist Manager
Acutaas Chemicals Ltd Logo
Acutaas Chemicals Ltd
NSE:ACUTAAS
Watchlist
Price: 1 666.9 INR 0.96% Market Closed
Market Cap: 136.5B INR

Acutaas Chemicals Ltd
Cash Paid for Dividends

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Acutaas Chemicals Ltd
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Acutaas Chemicals Ltd
NSE:ACUTAAS
Cash Paid for Dividends
-₹122.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash Paid for Dividends
-₹6.7B
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash Paid for Dividends
-₹12.9B
CAGR 3-Years
-47%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash Paid for Dividends
-₹37.3B
CAGR 3-Years
-16%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Cash Paid for Dividends
-₹5.5B
CAGR 3-Years
-44%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash Paid for Dividends
-₹10.8B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
No Stocks Found

Acutaas Chemicals Ltd
Glance View

Market Cap
136.5B INR
Industry
Pharmaceuticals

Acutaas Chemicals Ltd. engages in the development and commercialization of pharmaceutical intermediate products and specialty chemicals. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-09-14. The company is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. The company manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. The company has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.

ACUTAAS Intrinsic Value
1 190.33 INR
Overvaluation 29%
Intrinsic Value
Price

See Also

What is Acutaas Chemicals Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-122.8m INR

Based on the financial report for Mar 31, 2025, Acutaas Chemicals Ltd's Cash Paid for Dividends amounts to -122.8m INR.

What is Acutaas Chemicals Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 1Y
-12%

Over the last year, the Cash Paid for Dividends growth was -12%.

Back to Top